Objectives: To review the cases of atypical squamous cells (ASC), cannot exclude squamous intraepithelial lesion (ASC-H) diagnosed at a single institution and to discuss the interpretation challenges and clinical management of these cases. Study Design: The ASC-H cases diagnosed at our institution from 2006 to 2015 were studied retrospectively; of 159,000 Pap smears, there were 959 cases of ASC of undetermined significance (ASC-US) and 148 cases of ASC-H. We have reviewed the clinical records of the ASC-H cases, and data have been analyzed using SPSS 20.0. Results: Median age was 43.1 years; 49.6% of the patients had previous cervical cytologies, and 55.9% of them were negative. Following ASC-H diagnosis, another smear was obtained in 97.1% of the cases and in 67.6% a biopsy was performed. Biopsy revealed low-grade dysplasia in 18.8% of the cases, high-grade dysplasia in 27.8%, and infiltrating carcinoma in 2.3%. Patients with significant lesions in histology were younger than patients with negative results (p = 0.08). A diagnosis of ASC-H/squamous intraepithelial lesion in the repeated cytology had a sensitivity of 74.2%, specificity of 39.6%, positive predictive value of 44.8%, and negative predictive value of 70% for the diagnosis of dysplasia. Conclusions: ASC-H diagnosis is associated with a high incidence of histological high-grade lesions. A repeat cytology can aid in the selection of high-risk patients, but there may be false-negative results.

Keywords:
ASC-H, Atypical squamous cells, Bethesda system, Cervical cancer, Cervical intraepithelial neoplasia, Cervical cytology, High-grade squamous intraepithelial lesion, Squamous intraepithelial lesion
1.
Nogara PRB, Manfroni LAR, Consolaro MEL: Cervical cytology of atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H): histological results and recurrence after a loop electrosurgical excision procedure. Arch Gynecol Obstet 2011;284:965-971.
2.
You K, Guo Y, Gen L, Qiao J: The risk of CIN II or greater in a one-year follow-up period in patients with ASC-H interpreted with cytology. Eur J Obstet Gynecol Reprod Biol 2010;149:215-217.
3.
Barreth D, Schepansky A, Capstick V, Johnson G, Steed H, Faught W: Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. J Obstet Gynaecol Canada 2006;28:1095-1098.
4.
Gilani SM, Tashjian R, Fathallah L: Cervical cytology with a diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a follow-up study with corresponding histology and significance of predicting dysplasia by human papillomavirus (HPV) DNA testing. Arch Gynecol Obstet 2014;289:645-648.
5.
Saad RS, Dabbs DJ, Kordunsky L, Kanbour-Shakir A, Silverman JF, Liu Y, et al: Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol 2006;126:381-388.
6.
Gupta N, Crossley J, Dudding N, Ellis K, Smith JHF: Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic features in SurePath™ cervical samples. Diagn Cytopathol 2013;41:520-526.
7.
Abati A, Jaffurs W, Wilder AM: Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998;84:218-225.
8.
Atjimakul T, Boonyapipat S, Chichareon S, Phukaoloun M: Cytomorphologic and clinical factors of having high-grade cervical intraepithelial neoplasia/invasive carcinoma in women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H) smears. J Med Assoc Thai 2013;96:1389-1394.
9.
Mokhtar GA, Delatour NLDR, Assiri AH, Gilliatt MA, Senterman M, Islam S: Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls. Acta Cytol 2008;52:169-177.
10.
Ozlem A, Umit I: Comparative analysis of cervical cytology screening methods and staining protocols for detection rate and accurate interpretation of ASC-H: data from a high-volume laboratory in Turkey. Diagn Cytopathol 2015;43:863-869.
11.
Cohen D, Austin RM, Gilbert C, Freij R, Zhao C: Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results. Am J Clin Pathol 2012;138:517-523.
12.
Gupta S, Sodhani P: Reducing ‘atypical squamous cells' overdiagnosis on cervicovaginal smears by diligent cytology screening. Diagn Cytopathol 2012;40:764-769.
13.
Duncan LD, Jacob SV: Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category. Diagn Cytopathol 2005;32:243-246.
14.
Liman AK, Giampoli EJ, Bonfiglio TA: Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Cancer 2005;105:457-460.
15.
Huitron S, Bonvicino A, Fadare O: Patients with negative cervical biopsies after Papanicolaou test interpretations of ‘atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion': comparative longitudinal follow-up. Ann Diagn Pathol 2008;12:187-190.
16.
Bonvicino A, Huitron S, Fadare O: Papanicolaou test interpretations of ‘atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion' : an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice. Cancer 2007;111:477-481.
17.
Simsir A, Ioffe O, Sun P, Elgert P, Cangiarella J, Levine PH: Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H). Diagn Cytopathol 2006;34:62-66.
18.
Xu L, Verdoodt F, Wentzensen N, Bergeron C, Arbyn M: Triage of ASC-H: a meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer. Cancer Cytopathol 2016;124:261-272.
19.
Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N: Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer 2008;114:481-488.
20.
Onuma K, Saad RS, Kanbour-Shakir A, Kanbour AI, Dabbs DJ: Clinical implications of the diagnosis ‘atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion' in pregnant women. Cancer 2006;108:282-287.
21.
Cytryn A, Russomano FB, Camargo MJ, Zardo LMG, Horta NMSR, Fonseca Rde C, et al: Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out. São Paulo Med J 2009;127:283-287.
22.
Lee S, Kim JW, Hong JH, Song JY, Lee JK, Kim IS, et al: Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. Diagn Cytopathol 2014;42:1058-1062.
23.
Evans MF, Adamson CS-C, Papillo JL, St John TL, Leiman G, Cooper K: Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-1064.
24.
Srodon M, Parry Dilworth H, Ronnett BM: Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results. Cancer 2006;108:32-38.
25.
Biscotti CV, Dawson AE, Dziura B, Galup L, Darragh T, Rahemtulla A, et al: Assisted primary screening using the automated ThinPrep Imaging System. Am J Clin Pathol 2005;123:281-287.
26.
Ahn S, Lee Y-Y, Sung J-Y, Lee JJ, Oh YL, Sung CO, et al: Body mass index and outcome of ASC-H-interpreted cervical smears in postmenopausal women. Acta Cytol 2012;56:259-265.
27.
Negri G, Menia E, Egarter-Vigl E, Vittadello F, Mian C: ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears. Cancer 2003;99:342-345.
28.
Kietpeerakool C, Srisomboon J, Tantipalakorn C, Suprasert P, Khunamornpong S, Nimmanhaeminda K, et al: Underlying pathology of women with ‘atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion' smears, in a region with a high incidence of cervical cancer. J Obstet Gynaecol Res 2008;34:204-209.
29.
López-Alegría F, De Lorenzi DS, Quezada OP: Follow-up of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions (ASC-H). São Paulo Med J 2014;132:15-22.
30.
Selvaggi SM: Clinical significance of atypical squamous cells cannot exclude high grade squamous intraepithelial lesion with histologic correlation-: a 9-year experience. Diagn Cytopathol 2013;41:943-946.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.